Skip NavigationSkip to Content

Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, follistatin, activin-A, and DHT

  1. Author:
    Wang, M.
    Liu, A.
    Garcia, F. U.
    Rhim, J. S.
    Stearns, M. E.
  2. Author Address

    Stearns ME MCP Hahnemann Univ, Dept Pathol & Lab Med Broad & Vine St Philadelphia, PA 19102 USA MCP Hahnemann Univ, Dept Pathol & Lab Med Philadelphia, PA 19102 USA NCI, NIH Frederick, MD 21701 USA
    1. Year: 1999
  1. Journal: International Journal of Oncology
    1. 14
    2. 6
    3. Pages: 1185-1195
  2. Type of Article: Article
  1. Abstract:

    Cultures from high grade prostatic intraepithelial neoplasia (HGPIN) have been established and immortalized by HPV-18 infection. The cultures were identified as PIN by Western blotting with anti-cytokeratin (34 beta E12) and prostate specific antigen (PSA) antibodies. We examined the growth capabilities of the cultures in the presence of TGF-beta 1, activin-A, follistatin (FS), androgens (DHEA, DHT) and several cytokines (IL-10, IL-2, IL-4). IL-10, FS, and DHT stimulated cell proliferation and colony forming ability, while the other cytokines and growth factors had no discernable effect. In addition, DHT and to a lesser extent IL-10 both stimulated PSA production. Activin-A blocked IL-10, FS, and DHT stimulated growth and PSA production. We interpret the data to mean that IL-IO induction of FS secretion (and FS binding of activin A) restores the normal growth capabilities of HGPIN cultures. [References: 46]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel